Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1997-04-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.94.9.4772PMID 9114067PMCID PMC20800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt

  1997cited by this paper
• Presence and differential internalization of two distinct insulin-like growth factor receptors in rat hippocampal neurons.

  1997cited by this paper
• Insulin receptor substrate 1 and 2 (IRS1 and IRS2): what a tangled web we weave.

  1996cited by this paper
• Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide.

  1996cited by this paper
• The Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐Protein a

  1996cited by this paper
• Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils

  1996cited by this paper
• Transforming growth factors-β protect primary rat hippocampal neuronal cultures from degeneration induced by β-amyloid peptide

  1996cited by this paper
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996cited by this paper
• The molecular significance of amyloid beta-peptide for Alzheimer's disease.

  1996cited by this paper
• RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

  1996cited by this paper
• Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils.

  1996cited by this paper
• Degradation of Amyloid -Protein by a Serine Protease--Macroglobulin Complex (*)

  1996cited by this paper
• The role of APP processing and trafficking pathways in the formation of amyloid beta-protein.

  1996cited by this paper
• The effects of insulin-like growth factor analogues on survival of cultured cerebral cortex and cerebellar granule neurones.

  1996cited by this paper
• Regulation of APP Processing by Intra‐ and Intercellular Signals a

  1996cited by this paper
• Autocrine—paracrine Regulation of Hippocampal Neuron Survival by IGF‐1 and the Neurotrophins BDNF, NT‐3 and NT‐4

  1996cited by this paper
• Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

  1996cited by this paper
• Degradation of amyloid beta-protein by a serine protease-alpha2-macroglobulin complex.

  1996cited by this paper
• Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons.

  1995cited by this paper
• Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation.

  1995cited by this paper
• The toxicity in vitro of beta-amyloid protein.

  1995cited by this paper
• Amyloid peptides are toxic via a common oxidative mechanism.

  1995cited by this paper
• Apoptotic cell death induced by beta-amyloid 1-42 peptide is cell type dependent.

  1995cited by this paper
• The Intracellular Component of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction Is Specifically Inhibited by β‐Amyloid Peptides

  1995cited by this paper
• Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

  1995cited by this paper
• Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis.

  1995cited by this paper
• Molecular and cellular aspects of the insulin-like growth factor I receptor.

  1995cited by this paper
• Amyloid beta amyloidosis in Alzheimer's disease.

  1995cited by this paper
• Ligand-dependent G Protein Coupling Function of Amyloid Transmembrane Precursor (*)

  1995cited by this paper
• Insulin-like growth factor II is induced during wound repair following hypoxic-ischemic injury in the developing rat brain.

  1995cited by this paper
• The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors.

  1995cited by this paper
• Apoptotic Cell Death Induced by β‐Amyloid1–42 Peptide Is Cell Type Dependent

  1995cited by this paper
• The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.

  1995cited by this paper
• Centrally administered insulin and IGF-1 in transient forebrain ischaemia in fasted rats.

  1994cited by this paper
• Neurodegeneration, Alzheimer's disease, and beta-amyloid toxicity.

  1994cited by this paper
• Amyloid beta peptide induces necrosis rather than apoptosis.

  1994cited by this paper
• Hydrogen peroxide mediates amyloid beta protein toxicity.

  1994cited by this paper
• Normal and abnormal biology of the beta-amyloid precursor protein.

  1994cited by this paper
• c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines.

  1994cited by this paper
• Life without the IRS

  1994cited by this paper
• Insulin. Life without the IRS.

  1994cited by this paper
• Amyloid β peptide induces necrosis rather than apoptosis

  1994cited by this paper
• Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity.

  1994cited by this paper
• Staurosporine and K-252 compounds protect hippocampal neurons against amyloid beta-peptide toxicity and oxidative injury.

  1994cited by this paper
• Inhibitors of free radical formation fail to attenuate direct β‐amyloid25–35 peptide‐mediated neurotoxicity in rat hippocampal cultures

  1994cited by this paper
• Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP.

  1993cited by this paper
• beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.

  1993cited by this paper
• Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35.

  1993cited by this paper
• β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease

  1993cited by this paper
• Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.

  1993cited by this paper
• Entorhinal cortex lesion induces differential responses in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in the rat hippocampal formation.

  1993cited by this paper
• beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

  1993cited by this paper
• β‐Amyloid Neurotoxicity in Human Cortical Culture Is Not Mediated by Excitotoxins

  1993cited by this paper
• Neurotoxicity of Human Amylin in Rat Primary Hippocampal Cultures: Similarity to Alzheimer's Disease Amyloid‐β Neurotoxicity

  1993cited by this paper
• Complex maze performance in young and aged rats: response to glucose treatment and relationship to blood insulin and glucose.

  1992cited by this paper
• Insulin‐Like Growth Factor I Receptor Binding in Brains of Alzheimer's and Alcoholic Patients

  1992cited by this paper
• Promotion of beta-structure by interaction of diabetes associated polypeptide (amylin) with phosphatidylcholine.

  1992cited by this paper
• IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage

  1992cited by this paper
• Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells.

  1992cited by this paper
• Developmental expression, compartmentalization, and possible role in excitotoxicity of a putative NMDA receptor protein in cultured hippocampal neurons.

  1991cited by this paper
• Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation.

  1991cited by this paper
• High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan.

  1991cited by this paper
• Nerve growth factor potentiates the neurotoxicity of beta amyloid.

  1990cited by this paper
• Regional distribution and molecular forms of rat islet amyloid polypeptide.

  1990cited by this paper
• Determination of the number of endothelial cells in culture using an acid phosphatase assay.

  1986cited by this paper

• Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer’s disease

  2025cites this paper
• Understanding the Intersection Between Hormonal Dynamics and Brain Plasticity in Alzheimer's Disease: A Narrative Review for Implementing New Therapeutic Strategies

  2025cites this paper
• The Insulin-like Growth Factor Family as a Potential Peripheral Biomarker in Psychiatric Disorders: A Systematic Review

  2025cites this paper
• Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies

  2024cites this paper
• Does the liver facilitate aging‐related cognitive impairment: Conversation between liver and brain during exercise?

  2024cites this paper
• Retracted Article: The interaction between insulin resistance and Alzheimer’s disease: a review article

  2024cites this paper
• Cyclic Glycine-Proline Improves Memory and Reduces Amyloid Plaque Load in APP/PS1 Transgenic Mouse Model of Alzheimer's Disease

  2023cites this paper
• “Adjust Zang and arouse spirit” electroacupuncture ameliorates cognitive impairment by reducing endoplasmic reticulum stress in db/db mice

  2023cites this paper
• Insulin-like growth factor in Parkinson's disease is related to nonmotor symptoms and the volume of specific brain areas.

  2022cites this paper
• A novel approach to type 3 diabetes mechanism: The interplay between noncoding RNAs and insulin signaling pathway in Alzheimer's disease

  2022cites this paper
• Metformin: Is it a drug for all reasons and diseases?

  2022cites this paper
• Hyper-glycemia and insulinemia induce morphological changes and modulate secretion of S100B, S100A8, amyloid β 1-40 and amyloid β 1-42, in a model of human dopaminergic neurons.

  2022cites this paper
• Insulin‐like growth factor 1 gene transfer for sporadic Alzheimer's disease: New evidence for trophic factor mediated hippocampal neuronal and synaptic recovery‐based behavior improvement

  2021cites this paper
• Insulin-like growth factor reduced against decabromodiphenyl ether-209–induced neurodevelopmental toxicity in vivo and in vitro

  2021cites this paper
• The Involvement of Insulin-Like Growth Factor 1 and Nerve Growth Factor in Alzheimer’s Disease-Like Pathology and Survival Role of the Mix of Embryonic Proteoglycans: Electrophysiological Fingerprint, Structural Changes and Regulatory Effects on Neurotrophins

  2021cites this paper
• Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer’s Disease

  2021cites this paper
• Therapeutic effects of non-saponin fraction with rich polysaccharide from Korean red ginseng on aging and Alzheimer's disease.

  2021cites this paper
• Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings

  2021cites this paper
• Insulin and Insulin Resistance in Alzheimer’s Disease

  2021cites this paper
• Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease

  2020cites this paper
• Influence of human amylin on the membrane stability of rat primary hippocampal neurons

  2020cites this paper
• Diabetes and the Nervous System

  2020cites this paper
• The role of mitochondria-associated membranes in cellular homeostasis and diseases.

  2020cites this paper
• Insulin-Like Growth Factor I (IGF-I); cytoprotective effects, idea of replacement therapy in the healthy elderly subjects

  2020cites this paper
• Revisiting the Role of Insulin-Like Growth Factor-I Receptor Stimulating Activity and the Apolipoprotein E in Alzheimer’s Disease

  2019cites this paper
• Identification of fermented tea (Camellia sinensis) polyphenols and their inhibitory activities against amyloid-beta aggregation.

  2019cites this paper
• The association between serum insulin-like growth factor 1 and cognitive impairments in patients with schizophrenia.

  2019cites this paper
• The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins in the Nervous System

  2019cites this paper
• The role of Insulin-like Growth Factors (IGFs) and IGF-binding proteins in the nervous system

  2019cites this paper
• The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease.

  2019cites this paper
• Circulating IGFBP‐2: a novel biomarker for incident dementia

  2019cites this paper
• 40 YEARS of IGF1: IGF1: the Jekyll and Hyde of the aging brain.

  2018cites this paper
• IGF-I Gene Therapy in Aging Rats Modulates Hippocampal Genes Relevant to Memory Function

  2018cites this paper
• 40 YEARS of IGF1 IGF1: the Jekyll and Hyde of the aging brain

  2018cites this paper
• IGF-1 : The Jekyll & Hyde of the aging brain

  2018cites this paper
• Hormones of energy homeostasis : linking weight loss and cognition in Parkinson's disease?

  2018cites this paper
• Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment

  2018cites this paper
• Implication of Oxidative Stress, Aging, and Inflammatory Processes in Neurodegenerative Diseases: Growth Factors as Therapeutic Approach

  2018cites this paper
• Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia

  2018cites this paper
• Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson’s disease

  2017cites this paper
• Insulin-like growth factor binding protein-2 interactions with Alzheimer’s disease biomarkers

  2017cites this paper
• Cytokines, cortisol and IGF-1 in first episode psychosis and ultra high risk males. Evidence for TNF-α, IFN-γ, ΤNF-β, IL-4 deviation.

  2017cites this paper
• Amylin in Alzheimer's disease: Pathological peptide or potential treatment?

  2017cites this paper
• Therapeutic potential of IGF-I on hippocampal neurogenesis and function during aging

  2017cites this paper
• Protective effect of nordihydroguaiaretic acid (NDGA) on the transgenic Drosophila model of Alzheimer's disease.

  2017cites this paper
• Epigenetic regulation of HDAC1 SUMOylation as an endogenous neuroprotection against Aβ toxicity in a mouse model of Alzheimer's disease

  2017cites this paper
• Insulin‐like growth factor‐1 protects SH‐SY5Y cells against &bgr;‐amyloid‐induced apoptosis via the PI3K/Akt‐Nrf2 pathway

  2017cites this paper
• Microarray Analysis of microRNAs Expression Profiles in Adult and Aged Mice Hippocampus

  2017cites this paper
• IGF-1 protects against Aβ25-35-induced neuronal cell death via inhibition of PUMA expression and Bax activation.

  2017cites this paper
• Serum insulin‐like growth factor‐I and amyloid beta protein in Alzheimer's disease: relationship with cognitive function

  2016cites this paper
• Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation

  2016cites this paper
• The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.

  2016cites this paper
• Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer’s Disease

  2016cites this paper
• Insulin‐like growth factor‐I gene therapy increases hippocampal neurogenesis, astrocyte branching and improves spatial memory in female aging rats

  2016cites this paper
• The Influences of Dietary Sugar and Related Metabolic Disorders on Cognitive Aging and Dementia

  2016cites this paper
• Association of insulin-like growth factor-I with the severity and outcomes of acute ischemic stroke

  2016cites this paper
• The Rationale for Insulin Therapy in Alzheimer’s Disease

  2016cites this paper
• Association of insulin-like growth factor-1 with mild cognitive impairment and slow gait speed.

  2015cites this paper
• Age-Related Decrease in Glucagon-Like Peptide-1 in Mouse Prefrontal Cortex but Not in Hippocampus Despite the Preservation of Its Receptor

  2015cites this paper
• Alzheimer’s Disease: Mechanism and Approach to Cell Therapy

  2015cites this paper
• IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer’s Disease Model Mice

  2014cites this paper
• Involvement of IGF-II receptors in the antioxidant and neuroprotective effects of IGF-II on adult cortical neuronal cultures.

  2014cites this paper
• The mother as hunter: significant reduction in foraging costs through enhancements of predation in maternal rats.

  2014cites this paper
• Impaired insulin signaling and mechanisms of memory loss.

  2014cites this paper
• Aktivitätsabhängige Genregulation von Neurotrophen Faktoren und Wachstumsfaktoren am transgenen Alzheimer Mausmodell

  2014cites this paper
• Neuroimmunological Aberrations and Cerebral Asymmetry Abnormalities in Schizophrenia: Select Perspectives on Pathogenesis

  2014cites this paper
• Insulin therapy modulates mitochondrial dynamics and biogenesis, autophagy and tau protein phosphorylation in the brain of type 1 diabetic rats.

  2014cites this paper
• Insulin‐like growth factor‐1 predicts cognitive functions at 2‐year follow‐up in early, drug‐naïve Parkinson's disease

  2014cites this paper
• Gene therapy and cell reprogramming for the aging brain: achievements and promise.

  2014cites this paper
• Use of Dietary Supplementation of Unsaturated Fatty Acids to Delay Onset of Learning and Memory Deficits in TgCRND8 Mice

  2014cites this paper
• Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

  2014cites this paper
• Unilateral injection of Aβ25–35 in the hippocampus reduces the number of dendritic spines in hyperglycemic rats

  2014cites this paper
• Subcellular targeting and dynamic regulation of PTEN: implications for neuronal cells and neurological disorders

  2014cites this paper
• Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia.

  2013cites this paper
• Expression of exogenous LIN28 contributes to proliferation and survival of mouse primary cortical neurons in vitro.

  2013cites this paper
• Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

  2013cites this paper
• Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals

  2013cites this paper
• Estrogens need insulin-like growth factor I cooperation to exert their neuroprotective effects in post-menopausal women

  2013cites this paper
• Insulin/IGF Signaling-Related Gene Expression in the Brain of a Sporadic Alzheimer's Disease Monkey Model Induced by Intracerebroventricular Injection of Streptozotocin

  2013cites this paper
• Insulin-like Growth Factor-1

  2013cites this paper
• BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer’s disease

  2013cites this paper
• Monitoring neurodegeneration in diabetes using adult neural stem cells derived from the olfactory bulb

  2013cites this paper
• Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology

  2013cites this paper
• Type 2 Diabetes Mellitus and Alzheimer's Disease: from physiopathology to treatment implications.

  2013cites this paper
• Metabolic Reserve as a Determinant of Cognitive Aging

  2012cites this paper
• Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.

  2012cites this paper
• Cerebrospinal Fluid and Serum Levels of Growth Hormone, Insulinlike Growth Factor 1, Insulinlike Growth Factor Binding Protein 3, and Ghrelin in Patients With Bacterial and Tuberculous Meningitis

  2012cites this paper
• The Insulin Regulatory Network in Adult Hippocampus and Pancreatic Endocrine System

  2012cites this paper
• Human Ageing and the Growth Hormone/Insulin-Like Growth Factor-I(GH/IGF-I) Axis - The Impact of Growth Factors on Dementia

  2012cites this paper
• Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.

  2012cites this paper
• Abnormality of glycometabolism related factors in non-psychotic offspring of schizophrenic patients.

  2012cites this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• On Aerobic Exercise and Behavioral and Neural Plasticity

  2012cites this paper
• Neural Stem Cells in the Adult Brain: From Benchside to Clinic

  2012cites this paper
• Contributions of Brain Insulin Resistance and Deficiency in Amyloid-Related Neurodegeneration in Alzheimer’s Disease

  2012cites this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• Stress And The Diabetes Mind: Job Loss Predicts Cognitive Function In The Health And Retirement Study

  2012cites this paper
• Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin

  2012cites this paper
• Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease.

  2012cites this paper
• Molecular interplay between leptin, insulin-like growth factor-1, and β-amyloid in organotypic slices from rabbit hippocampus

  2011cites this paper